Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 2/20 | 0.47 |
| ▸ | F2 | P00734 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | SRC | P12931 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | HRH1 | P35367 | 1/20 | 0.39 |
| ▸ | MTOR | P42345 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | GRM7 | Q14831 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12153197 | 0.84 | IDO1 (0.54) | TSHRCYP2D6LMNAMAPK1SLC6A2 | |
| SCHEMBL17118213 | 0.84 | LMNA (0.48) | TSHRLMNACES2CES1 | |
| SCHEMBL2009058 | 0.84 | IDO1 (0.52) | LMNAMTORRAB9ACES2 | |
| SCHEMBL11438243 | 0.82 | ALDH1A1 (0.50) | HTR2ATAAR1MAPK1 | |
| SCHEMBL11721312 | 0.79 | DPP4 (0.47) | DPP4F2TSHRHTR2ATAAR1 | |
| SCHEMBL329655 | 0.79 | — | — | |
| SCHEMBL24540206 | 0.78 | UGT2B7 (0.50) | CYP2D6SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL16771261 | 0.78 | TSHR (0.54) | TSHR | |
| SCHEMBL7717912 | 0.76 | DPP4 (0.35) | DPP4F2TSHRHTR2ATAAR1 | |
| SCHEMBL21392771 | 0.74 | CYP2C19 (0.46) | LMNAMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 348 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1939221-B1 | A METHOD FOR PRODUCING FUNCTIONALIZED CIS-1,4POLYDIENES HAVING HIGH CIS-1,4-LINKAGE CONTENT AND HIGH FUNCTIONALITY | BRIDGESTONE CORP (JP) | 2017-10-18 | — | — | EP | claimed |
| US-8017695-B2 | homo or copolymerizing 1,3-butadiene in prseence of a catalyst system containing lanthanium neodecanoate, methylaluminoxane, diisobutylaluminum hydride, diethylaluminum choride, followed by reacting reactive polymer with bis/diethylamino/benzophenone; narrow molecular weight distribution | BRIDGESTONE CORPORATION (JP) | 2011-09-13 | — | — | US | claimed |
| US-7825201-B2 | Process for producing polydienes | BRIDGESTONE CORPORATION (JP) | 2010-11-02 | — | — | US | claimed |
| US-20090299019-A1 | PROCESS FOR PRODUCING POLYDIENES | BRIDGESTONE CORPORATION (JP) | 2009-12-03 | — | — | US | claimed |
| US-20080182954-A1 | METHOD FOR PRODUCING FUNCTIONALIZED CIS-1,4-POLYDIENES HAVING HIGH CIS-1,4-LINKAGE CONTENT AND HIGH FUNCTIONALITY | BRIDGESTONE CORPORATION (JP) | 2008-07-31 | — | — | US | claimed |
| EP-1939221-A2 | A method for producing functionalized cis-1,4polydienes having high cis-1,4-linkage content and high functionality | Bridgestone Corporation (JP) | 2008-07-02 | — | — | EP | claimed |
| CN-1518469-A | Dermatological preparations | �����ɷ� | 2004-08-04 | — | — | CN | claimed |
| US-6498200-B1 | OXIRANE OR OXETANE RING COMPOUND, ORGANIC PEROXIDE, ONIUM SALT CATALYST, AND ALKALINE FILLER; CURES RAPIDLY; STABLE DOES NOT CAUSE INCREASE IN ELECTROCONDUCTIVITY OR CORROSION; SEALANT, BINDER, ENCAPSULATING AGENT, DIELECTRIC FILM | NAMICS CORPORATION (JP) | 2002-12-24 | — | — | US | claimed |
| EP-4737489-A1 | CATALYST COMPOSITION PREPARATION METHOD AND CONJUGATED DIENE-BASED POLYMER PREPARATION METHOD | LG CHEM, LTD. (KR) | 2026-05-06 | — | — | EP | disclosed |
| US-12617879-B2 | Neodymium-catalyzed conjugated diene-based polymer and rubber composition comprising same | LG CHEM, LTD. (KR) | 2026-05-05 | — | — | US | disclosed |
| US-12565546-B2 | Imine group-containing novel compound, modified conjugated diene-based polymer including same, method for preparing the polymer, and rubber composition including the polymer | LG CHEM, LTD. (KR) | 2026-03-03 | — | — | US | disclosed |
| US-12534563-B2 | Block copolymer, resin composition, stretch conductor, electronic device, and pressure-sensitive adhesive film | ARTIENCE CO., LTD. (JP) | 2026-01-27 | — | — | US | disclosed |
| EP-4653475-A1 | CONJUGATED DIENE-BASED POLYMER AND RUBBER COMPOSITION | LG CHEM, LTD. (KR) | 2025-11-26 | — | — | EP | disclosed |
| EP-4653477-A1 | CONJUGATED DIENE-BASED POLYMER AND RUBBER COMPOSITION | LG CHEM, LTD. (KR) | 2025-11-26 | — | — | EP | disclosed |
| US-6498200-B1 | OXIRANE OR OXETANE RING COMPOUND, ORGANIC PEROXIDE, ONIUM SALT CATALYST, AND ALKALINE FILLER; CURES RAPIDLY; STABLE DOES NOT CAUSE INCREASE IN ELECTROCONDUCTIVITY OR CORROSION; SEALANT, BINDER, ENCAPSULATING AGENT, DIELECTRIC FILM | NAMICS CORPORATION (JP) | 2002-12-24 | — | — | US | disclosed |
| EP-0034924-B1 | PROCESS FOR PREPARING 3-IODOMETHYL CEPHALOSPORINS | ELI LILLY AND COMPANY (US) | 1984-07-04 | — | — | EP | disclosed |
| EP-0034924-A2 | Process for preparing 3-iodomethyl cephalosporins | ELI LILLY AND COMPANY (US) | 1981-09-02 | — | — | EP | disclosed |
| US-4266049-A | Process for 3-iodomethyl cephalosporins | ELI LILLY AND COMPANY (US) | 1981-05-05 | — | — | US | disclosed |
| US-4188226-A | OXIDIZER, REDUCER, HALOGENATED CARBOCYCLIC COMPOUND | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1980-02-12 | — | — | US | disclosed |
| US-4011375-A | POLYOLEFINS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 1977-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12565546-B2 | Imine group-containing novel compound, modified conjugated diene-based polymer including same, method for preparing the polymer, and rubber composition including the polymer | CARM1, RIF1, UFM1 | DPP4 4884/4885F2 623/4885TSHR 2424/4885 |
| US-12534563-B2 | Block copolymer, resin composition, stretch conductor, electronic device, and pressure-sensitive adhesive film | EPB41, ITGB4, ITGB5 | DPP4 4196/4885F2 2463/4885TSHR 657/4885 |
| US-12617879-B2 | Neodymium-catalyzed conjugated diene-based polymer and rubber composition comprising same | RPA1, RAD1, COL1A1 | DPP4 4735/4885F2 20/4885TSHR 2744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.